Health State Values for Use in the Economic Evaluation of Treatments for Alzheimer's Disease

ISSN： 1170-229X

Source： Drugs & Aging, Vol.29, Iss.1, 2012-01, pp. : 31-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developing Adolescent-Specific Health State Values for Economic Evaluation: An Application of Profile Case Best-Worst Scaling to the Child Health Utility 9D

By Ratcliffe Julie

PharmacoEconomics, Vol. 30, Iss. 8, 2012-08 ,pp. : 713-727

Adis International

Access to resources Recommend Favorite

New and emerging treatments for Alzheimer's disease

By Corbett Anne Ballard Clive

Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. : 147-156

Informa Healthcare

Access to resources Recommend Favorite

Drug Treatments in Development for Alzheimer's Disease

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 42, Iss. 1, 2012-03 ,pp. : 58-65

John Wiley & Sons Inc

Access to resources Recommend Favorite

The State of Health Economic Evaluation Research in Nigeria: A Systematic Review

By Gavaza Paul Rascati Karen L. Oladapo Abiola O. Khoza Star

PharmacoEconomics, Vol. 28, Iss. 7, 2010-07 ,pp. : 539-553

Adis International

Access to resources Recommend Favorite

Assessing the Health and Economic Impact of Galantamine Treatment in Patients with Alzheimers Disease in the Health Care Systems of Different Countries

By Jaime Caro Maribel Salas

Drugs & Aging, Vol. 21, Iss. 10, 2004-01 ,pp. : 677-686

Adis International

Access to resources Recommend Favorite